We exhibit that these inhibitors suppress SLC15A4-mediated endolysosomal TLR and NOD capabilities in a variety of human and mouse immune cells; we offer proof of their capability to suppress inflammation in vivo As well as in clinical options; and we offer insights into their mechanism of action. Our results https://enricog208dmu6.eedblog.com/profile